Takeda bolsters global business development through new US unit
This article was originally published in Scrip
Executive Summary
Takeda has set up a new global business development group at its wholly owned Takeda Pharmaceuticals International subsidiary in the US, which will have broad responsibilities for product licensing and mergers and acquisitions.